Helpdesk

Sales contact

Home > Televisit

Televisit

Article

3 considerations to take into account when setting up an eCOA clinical trial

In a clinical trials environment that is moving increasingly towards digitalization and decentralization, it remains crucial to maintain high-quality electronic Clinical Outcome Assessments (eCOA) data. This is paramount to ensure...

Infographic

Televisits for more engaging clinical trials

Televisit

If it is important to enable televisits for DCT trials, embedding the feature directly into the eCOA app brings multiple...

Article

Televisits in clinical trials: Why integrate a telemedecine feature in your eCOA trials?

Televisit

With clinical trials digitalization and decentralization comes the possibility for patients to complete several of their clinical study procedures remotely,...

Subscribe to our newsletter

Breaking barriers in pediatric clinical trials: perspectives from two expert...

Ensure successful outcomes with strong patient collaboration at every stage...

Empowering healing: The impact of patient partnerships in clinical trials

Collecting PRO data in leukemia clinical research: the only way...

How to improve the collaboration between expert patients and healthcare...

Bringing the patient’s voice to clinical trials

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Kayentis Europe
19 bis, chemin du vieux Chêne
38240 Meylan
France
Phone: +33 (0)4 76 00 54 20

Kayentis US
186 South Street
Suite 600
Boston, Massachusetts 02111
USA